4896 — K Pharma Balance Sheet
0.000.00%
- ¥10bn
- ¥7bn
- ¥1bn
- 51
- 11
- 66
- 35
Annual balance sheet for K Pharma, fiscal year end - December 31st, JPY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|
Period Length: | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | Yuho |
Standards: | JAS | JAS | JAS |
Status: | Final | Final | Final |
Cash and Equivalents | |||
Cash and Short Term Investments | 189 | 1,337 | 3,266 |
Total Inventory | |||
Prepaid Expenses | |||
Total Other Current Assets | |||
Total Current Assets | 205 | 1,371 | 3,309 |
Other Long Term Assets | |||
Total Assets | 206 | 1,375 | 3,314 |
Accounts Payable | |||
Accrued Expenses | |||
Notes Payable / Short Term Debt | |||
Total Other Current Liabilities | |||
Total Current Liabilities | 23.4 | 33.7 | 178 |
Total Long Term Debt | |||
Total Debt | |||
Total Other Liabilities | |||
Total Liabilities | 26.9 | 38.3 | 209 |
Common Stock | |||
Additional Paid In Capital | |||
Retained Earnings (Accumulated Deficit) | |||
Other Equity | |||
Total Equity | 179 | 1,336 | 3,105 |
Total Liabilities & Shareholders' Equity | 206 | 1,375 | 3,314 |
Total Common Shares Outstanding |